R&D Trends

Mersana Therapeutics, Merck ink $792 million agreement

Wednesday, June 25, 2014 02:08 PM

Mersana Therapeutics and the biopharmaceutical division of Merckhave agreed to collaboratively develop next-generation antibody-drug conjugates (ADCs). ADCs are composed of an antibody linked to cytotoxic drugs, whereby the antibody specifically targets and delivers the cytotoxic drug to cancer cells, which could lead to higher drug levels at the tumor site.

More... »

WIRB Copernicus Group

UC San Diego initiates Cal-BRAIN program

Wednesday, June 25, 2014 01:55 PM

The California budget signed by Gov. Jerry Brown on June 20 created a statewide research grants program called Cal-BRAIN, an initiative led by UC San Diego. With an initial allocation of $2 million, Cal-BRAIN—short for California Blueprint for Research to Advance Innovations in Neuroscience—is a state complement to the federal BRAIN Initiative announced by President Barack Obama in April 2013. It aims to accelerate the development of brain mapping techniques, including the development of new technologies.

More... »

CRF Health eCOA webinar series

Bionomics, Merck enter research collaboration

Wednesday, June 25, 2014 01:47 PM

Bionomics has entered into an exclusive research collaboration and license agreement with Merck for its BNC375 research program targeting cognitive dysfunction associated with Alzheimer's disease and other central nervous system conditions.  

More... »

Global Care Initiative looks to Boston for U.S. life science research partners

Monday, June 23, 2014 01:36 PM

Global Care Initiative(GCI), a consortium of five nonprofit French research institutes, intends to have a representative in Boston, Mass., as it expands in search of U.S. life science research partners.

More... »

Johnson & Johnson Innovation announces 12 new life science alliances

Friday, June 20, 2014 02:10 PM

Johnson & Johnson Innovation has announced 12 new alliances with life science companies and research institutions around the globe to explore early-stage innovation in a broad range of therapeutic areas and across pharmaceuticals, medical device and diagnostics and consumer healthcare.

More... »

BIND Therapeutics, Roche collaborate on discovery of novel nanomedicines

Friday, June 20, 2014 12:07 PM

BIND Therapeutics, a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins, has entered into a research agreement with Roche to discover novel nanomedicines using Accurins for the treatment of diseases in therapeutic areas outside of oncology. The collaboration will focus on combining BIND's Accurin technology with Roche's proprietary therapeutic payloads and targeting ligands.

More... »

Report: More than 430 medicines in development for chronic diseases in elderly

Thursday, June 19, 2014 01:44 PM

America’s biopharmaceutical research companies are developing 435 innovative new medicines to target 15 leading chronic conditions affecting the Medicare population, according to a new report by the Pharmaceutical Research and Manufacturers of America (PhRMA).

More... »

Medical Research Council launches U.K. Dementias Research Platform

Thursday, June 19, 2014 01:39 PM

The Medical Research Council (MRC) has launched the U.K. Dementias Research Platform (UKDP), a $27.2 million public-private partnership set up to speed up research into dementias. The collaboration aims to enable earlier detection, improved treatment and, ultimately, prevention of the disease by looking not just at what is going wrong in the brain, but at the brain in the context of the whole body.

More... »

ADDC, AstraZeneca partner for drug development in academic research

Wednesday, June 18, 2014 12:54 PM

The Academic Drug Discovery Consortium (ADDC) has formed a collaboration with AstraZenecaaimed at facilitating efforts by researchers from academia and institutions toward the discovery of novel compounds with potential pharmaceutical application. More specifically, the goal of this partnership is to provide ADDC members with access to a high-quality compound library, while allowing AZ the opportunity to collaborate with academic researchers to identify novel disease targets and drugs across a wide range of therapy areas.

More... »

Sanofi, Medtronic form diabetes alliance to improve patient experience, outcomes

Wednesday, June 18, 2014 12:50 PM

Sanofi, a global healthcare provider, and Medtronic, a global medical technology provider, have entered into a global strategic alliance in diabetes, aimed at improving patient experience and outcomes for people with diabetes around the world. The alliance will initially focus on two key priorities: the development of drug-device combinations and delivery of care management services to improve adherence, simplify insulin treatment and help people with diabetes better manage their condition.

More... »

Subscribe to The CenterWatch Monthly
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

July 21

As job growth in drug development sector soars, more employees are seeking new opportunities

U.K. study: Prisoners should have the right to participatein clinical trials on moral grounds, for healthcare access

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

CRO market poised for growth and consolidation
Sponsors expanding pipelines, shrinking infrastructure fuel strategic outsourcing

Strategies for success evolving in phase I space
Sites see increasing complexity, more patients, greater focus on efficacy

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs